InvestorsHub Logo
Followers 59
Posts 7368
Boards Moderated 0
Alias Born 10/20/2014

Re: None

Thursday, 10/30/2014 8:31:54 PM

Thursday, October 30, 2014 8:31:54 PM

Post# of 423943
BIOBILLIONAIR... Why is it that AMRN will not partner with BP on indications such as dry eye or arthritis...when I asked IR about it they stated that they are focused on REDUCE-IT. This to me makes no sense. Any study for any indication takes time...why not have another company get the study completed and pay AMRN a royalty only on sales for that indication. This seems so senseless not to have several such deals in the works. Can anyone give me good reason as to why not? I guess I'm asking BB because I respect his opinion and I grateful for all the legal work he is doing.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News